{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:21Z","timestamp":1707524001683},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,18]]},"DOI":"10.7759\/cureus.36327","type":"journal-article","created":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T12:50:37Z","timestamp":1679143837000},"source":"Crossref","is-referenced-by-count":0,"title":["Progression to End-Stage Renal Disease Due to IgG4-Related Nephritis Refractory to Rituximab"],"prefix":"10.7759","author":[{"given":"Tien","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natallia","family":"Maroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101001","article-title":"Diagnosis and management of IgG4-related disease","volume":"10","author":"Hegade VS","year":"2019","unstructured":"Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of IgG4-related disease. Frontline Gastroenterol. 2019, 10:275-83. 10.1136\/flgastro-2018-101001","journal-title":"Frontline Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17071","article-title":"IgG4-related disease with renal and pulmonary involvement","volume":"13","author":"Osuorji C","year":"2021","unstructured":"Osuorji C, Master K, Osuorji I. IgG4-related disease with renal and pulmonary involvement. Cureus. 2021, 13:e17071. 10.7759\/cureus.17071","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa T","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, et al.. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003, 38:982-4. 10.1007\/s00535-003-1175-y","journal-title":"J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta M","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020, 369:m1067. 10.1136\/bmj.m1067","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace ZS","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al.. The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020, 72:7-19. 10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano M","year":"2011","unstructured":"Kawano M, Saeki T, Nakashima H, et al.. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011, 15:615-26. 10.1007\/s10157-011-0521-2","journal-title":"Clin Exp Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdtm.2017.05.003","article-title":"Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment","volume":"3","author":"Zheng K","year":"2017","unstructured":"Zheng K, Teng F, Li XM. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Dis Transl Med. 2017, 3:138-47. 10.1016\/j.cdtm.2017.05.003","journal-title":"Chronic Dis Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan VS","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014, 9:315-47. 10.1146\/annurev-pathol-012513-104708","journal-title":"Annu Rev Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_377_19","article-title":"IGg4-related disease presenting as rapidly progressive renal failure and inguinal Iymphadenopathy","volume":"31","author":"Anvar MI","year":"2021","unstructured":"Anvar MI, Iyenger JN, Mehta SS, Jagdeeshkumar B. IGg4-related disease presenting as rapidly progressive renal failure and inguinal Iymphadenopathy. Indian J Nephrol. 2021, 31:286-9. 10.4103\/ijn.IJN_377_19","journal-title":"Indian J Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_37_17","article-title":"Immunoglobulin G4-related tubulointerstitial nephritis: A not to be missed diagnosis","volume":"60","author":"Matthai SM","year":"2017","unstructured":"Matthai SM, Mohapatra A, Palak R, Basu G. Immunoglobulin G4-related tubulointerstitial nephritis: A not to be missed diagnosis. Indian J Pathol Microbiol. 2017, 60:577-80. 10.4103\/IJPM.IJPM_37_17","journal-title":"Indian J Pathol Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0676-5","article-title":"Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case study","volume":"18","author":"Ono H","year":"2017","unstructured":"Ono H, Murakami T, Mima A, et al.. Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case study. BMC Nephrol. 2017, 18:261. 10.1186\/s12882-017-0676-5","journal-title":"BMC Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25095","article-title":"IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy","volume":"9","author":"Quattrocchio G","year":"2018","unstructured":"Quattrocchio G, Barreca A, Demarchi A, et al.. IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy. Oncotarget. 2018, 9:21337-47. 10.18632\/oncotarget.25095","journal-title":"Oncotarget"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.271","article-title":"Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis","volume":"78","author":"Saeki T","year":"2010","unstructured":"Saeki T, Nishi S, Imai N, et al.. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010, 78:1016-23. 10.1038\/ki.2010.271","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1419-6","article-title":"IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review","volume":"20","author":"Zhang NN","year":"2019","unstructured":"Zhang NN, Wang YY, Kong LX, Zou WZ, Dong B. IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review. BMC Nephrol. 2019, 20:263. 10.1186\/s12882-019-1419-6","journal-title":"BMC Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0311-8","article-title":"Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review","volume":"7","author":"Zhang W","year":"2018","unstructured":"Zhang W, Glaze JH, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Rep. 2018, 7:137-42. 10.1007\/s13730-018-0311-8","journal-title":"CEN Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone JH","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012, 366:539-51. 10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001366","article-title":"Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature","volume":"94","author":"McMahon BA","year":"2015","unstructured":"McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. Rituximab for the treatment of IgG4-related tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015, 94:e1366. 10.1097\/MD.0000000000001366","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi A","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012, 91:57-66. 10.1097\/MD.0b013e3182431ef6","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers MN","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015, 74:1171-7. 10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142488-progression-to-end-stage-renal-disease-due-to-igg4-related-nephritis-refractory-to-rituximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:55Z","timestamp":1707508555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142488-progression-to-end-stage-renal-disease-due-to-igg4-related-nephritis-refractory-to-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.36327","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,18]]}}}